XML 110 R7.htm IDEA: XBRL DOCUMENT v3.19.3.a.u2
Consolidated Statements of Cash Flows
$ in Millions
12 Months Ended
Dec. 31, 2019
USD ($)
Dec. 31, 2018
USD ($)
Dec. 31, 2017
USD ($)
Cash flows from operating activities:      
Net income $ 209 $ 310 $ 440
Adjustments to reconcile net income to net cash provided by operating activities:      
Depreciation and amortization 104 63 48
Equity in earnings of unconsolidated affiliates (35) (79) (70)
Deferred income tax (benefit) expense (14) 26 (322)
Loss (gain) on disposition of assets (17) 2 (5)
Gain on consolidation of Aspire subcontracting entities 0 (108) 0
Other 34 24 29
Changes in operating assets and liabilities, net of acquired businesses:      
Accounts receivable, net of allowance for doubtful accounts (16) (203) 92
Contract assets (31) 25 40
Claims receivable 39 3 430
Accounts payable 23 112 (193)
Contract liabilities 19 (60) (198)
Accrued salaries, wages and benefits (9) 11 14
Payments from (advances to) unconsolidated affiliates, net 10 12 11
Distributions of earnings from unconsolidated affiliates 69 75 62
Pension funding (45) (41) (37)
Other assets and liabilities (84) (7) (148)
Total cash flows provided by operating activities 256 165 193
Cash flows from investing activities:      
Purchases of property, plant and equipment (20) (17) (8)
Investments in equity method joint ventures (146) (344) 0
Proceeds from sale of assets or investments 9 25 2
Acquisitions of businesses, net of cash acquired 0 (354) (4)
Adjustments to cash due to consolidation of Aspire entities 0 197 0
Other (1) 2 (2)
Total cash flows used in investing activities (158) (491) (12)
Cash flows from financing activities:      
Payments to reacquire common stock (4) (3) (53)
Acquisition of remaining ownership interest in joint ventures 0 (56) 0
Investments from noncontrolling interests 1 0 1
Distributions to noncontrolling interests (14) (3) (4)
Payments of dividends to shareholders (46) (44) (45)
Proceeds from sale of warrants 0 22 0
Purchase of note hedges 0 (62) 0
Issuance of convertible notes 0 350 0
Net proceeds from issuance of common stock 5 2 0
Excess tax benefits from share-based compensation 0 1 0
Borrowings on revolving credit agreement 0 250 0
Borrowings on long term debt 0 1,075 0
Payments on revolving credit agreement 0 (720) (180)
Payments on short-term and long-term borrowings (70) (100) (9)
Debt issuance costs 0 (57) 0
Other (5) (1) 0
Total cash flows provided (used) by financing activities (133) 654 (290)
Effect of exchange rate changes on cash 8 (28) 12
Increase (decrease) in cash and equivalents (27) 300 (97)
Cash and equivalents at beginning of period 739 439 536
Cash and equivalents at end of period 712 739 439
Supplemental disclosure of cash flows information:      
Cash paid for interest 80 52 21
Cash paid for income taxes (net of refunds) 54 21 144
Noncash investing activities      
Acquisition of technology licensing rights 0 16 0
Noncash financing activities      
Dividends declared $ 11 $ 11 $ 11